Amneal Pharmaceuticals, Inc.
AMRXNasdaqCIK 1723128HealthcareFiscal year ends Dec 31
Reports and events: 191 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-08-0516:39 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001723128-19-000111 |
| 2019-08-0506:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-19-000107 |
| 2019-08-0506:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-19-000105 |
| 2019-07-1916:51 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-19-005210 |
| 2019-07-1016:52 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-19-000100 |
| 2019-05-0916:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001723128-19-000081 |
| 2019-05-0916:16 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001723128-19-000079 |
| 2019-05-0906:42 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-19-000076 |
| 2019-03-2216:19 ET | DEF 14A | Proxy statementPeriod 2019-05-06 | 0001308179-19-000058 |
| 2019-03-0108:55 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-19-059421 |
| 2019-03-0108:31 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001723128-19-000028 |
| 2019-02-2808:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-19-000023 |
| 2019-01-2416:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001723128-19-000017 |
| 2019-01-0809:14 ET | 8-K | 7.01 Regulation FD disclosure | 0001723128-19-000011 |
| 2019-01-0716:23 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001723128-19-000005 |
| 2018-12-0716:24 ET | 8-K | 8.01 Other events | 0001723128-18-000039 |
| 2018-11-0716:51 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001723128-18-000037 |
| 2018-11-0707:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-18-000035 |
| 2018-08-0916:49 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001723128-18-000030 |
| 2018-08-0907:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-18-000027 |
| 2018-07-1219:25 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001723128-18-000024 |
| 2018-07-0917:17 ET | SC 13D | Ownership report, active investor | 0001193125-18-214805 |
| 2018-07-0917:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-18-214801 |
| 2018-07-0917:12 ET | SC 13D | Ownership report, active investor | 0001193125-18-214798 |
| 2018-07-0917:11 ET | SC 13D | Ownership report, active investor | 0001193125-18-214797 |
| 2018-07-0917:09 ET | SC 13D | Ownership report, active investor | 0001193125-18-214792 |
| 2018-07-0917:07 ET | SC 13D | Ownership report, active investor | 0001193125-18-214788 |
| 2018-06-0716:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-186843 |
| 2018-05-2108:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-18-000019 |
| 2018-05-1616:42 ET | 8-K | 2.05 Exit or disposal costs | 0001723128-18-000016 |
| 2018-05-1516:43 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001723128-18-000013 |
| 2018-05-1416:30 ET | SC 13D | Ownership report, active investor | 0001193125-18-162665 |
| 2018-05-1416:26 ET | SC 13D | Ownership report, active investor | 0000903423-18-000274 |
| 2018-05-1016:22 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001723128-18-000010 |
| 2018-05-0911:33 ET | S-1/A | Registration statement, amended | 0001193125-18-157112 |
| 2018-05-0710:02 ET | S-1 | Registration statement | 0001193125-18-153798 |
| 2018-05-0707:44 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-18-153558 |
| 2018-05-0707:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-153514 |
| 2018-04-1316:53 ET | S-1/A | Registration statement, amended | 0001193125-18-116990 |
| 2018-03-0917:00 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001723128-18-000005 |
| 2018-03-0717:11 ET | S-1 | Registration statement | 0001193125-18-073686 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 02:45 ET. Listed shows no prices and gives no investment advice.